Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Similar documents
Cardiopulmonary and anesthetic effects of the combination of butorphanol, midazolam and alfaxalone in Beagle dogs

Sedation in Children

Sedation For Cardiac Procedures A Review of

Pharmacology: Inhalation Anesthetics

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Side-effects of opioids what are they, are they common, and how do I deal with them?

COMPARATIVE ANAESTHETIC EFFICACY OF PROPOFOL, THIOPENTAL SODIUM AND COMBINATION OF PROPOFOL WITH KETAMINE HYDROCHLORIDE IN DOGS

Optimal sedation and management of anxiety in patients undergoing endobronchial ultrasound (EBUS)

Effects of alfaxalone on echocardiographic examination in healthy dogs

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Pharmacology of intravenous induction agents. Frederique S Servin APHP - Hôpital Bichat Paris FRANCE

SUMMARY OF PRODUCT CHARACTERISTICS

General Anesthesia. Mohamed A. Yaseen

Managing pain with opioid analgesics in cats and dogs

Sedation in children and young people. Appendix J. Sedation for diagnostic and therapeutic procedures in children and young people

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. 1 ml solution contains 75 micrograms of sufentanilcitrate, corresponding to 50 micrograms of sufentanil.

May 2013 Anesthetics SLOs Page 1 of 5

EFFECTS OF CONCURRENT ADMINISTRATION OF BUPIVACAINE ON THE HYPNOSIS OF THIOPENTONE IN DOGS

Pharmacology of intravenous induction agents

Induction of Anaesthesia

Pain & Sedation Management in PICU. Marut Chantra, M.D.

ULTIVA. Remifentanil hydrochloride

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

Use of methadone in young animals, geriatric animals, and those with concurrent disease

ANNEX III LABELLING AND PACKAGE LEAFLET

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 24 June 2009

Shaded areas=not MARKETED 24/2/09

Chapter 25. General Anesthetics

Procedural Sedation and Analgesia in the ED

ULTIVA GlaxoSmithKline

General anesthesia. No single drug capable of achieving these effects both safely and effectively.

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

PHYSICIAN COMPETENCY FOR ADULT DEEP SEDATION (Ages 14 and older)

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

PRINCIPLES OF SMALL ANIMAL ANESTHESIA & PERIOPERATIVE ANALGESIA Obiettivo n 24 - Sanità veterinaria. MODULE 1: May 8, 2014

Using methadone alongside other opioids. Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

HOW LOW CAN YOU GO? HYPOTENSION AND THE ANESTHETIZED PATIENT.

Intravenous Anesthetics studies from microsomes to big animals! Professor John SEAR University of Oxford, UK ISAP 2014

A specific opioid antagonist, such as naloxone immediately and completely reverses all actions of alfentanil.

Introduction to Anesthesia

DATA SHEET. Remifentanil hydrochloride for injection1mg and 2mg (remifentanil base) vials

This guidance is to be added as an appendix to the BSG guideline Safety and Sedation during Endoscopic Procedures. 1

Advanced Medical Care: Improving Veterinary Anesthesia. Advanced Medical Care: Improving Veterinary Anesthesia

Ideal Sedative Agent. Benzodiazepines 11/12/2013. Pharmacology of Benzodiazepines Used for Conscious Sedation in Dentistry.

Ideal Sedative Agent. Pharmacokinetics. Benzodiazepines. Pharmacodynamics 11/11/2013

P-RMS: NO/H/PSUR/0009/001

POST-INTUBATION ANALGESIA AND SEDATION. August 2012 J Pelletier

The Top 5 Anesthetic Complications Donna M. Sisak, CVT, LVT, VTS (Anesthesia/Analgesia) Seattle Veterinary Specialists Kirkland, WA

Sedation is a dynamic process.

Anesthesia: Analgesia: Loss of bodily SENSATION with or without loss of consciousness. Absence of the sense of PAIN without loss of consciousness

Anaesthetic considerations for laparoscopic surgery in canines

Inadvertent Ketamine Overdose in Children: Clinical Manifestations and Outcome

Analgesic-Sedatives Drug Dose Onset

General Anesthesia. My goal in general anesthesia is to stop all of these in the picture above (motor reflexes, pain and autonomic reflexes).

MORPHINE ADMINISTRATION

Induction Agents 2013/05/28 1

Chapter 004 Procedural Sedation and Analgesia

New Methods for Analgesia Delivery

Final Core Safety Profile for propofol 10 mg/ml (1%) and 20 mg/ml (2%) emulsion for injection or infusion

GUIDELINES ON CONSCIOUS SEDATION FOR DENTAL PROCEDURES

Trauma Patient. Trauma Patient. Anesthesia of the Acute Trauma Patient

PART 1.B SPC, LABELLING AND PACKAGE LEAFLET

The Game Plan. Should I Be Doing This? The Perfect Drug. Procedural Sedation

Series 2 dexmedetomidine, tramadol, fentanyl, intellectually disabled patients:

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

SWISS SOCIETY OF NEONATOLOGY. Prolonged arterial hypotension due to propofol used for endotracheal intubation in a newborn infant

Procedural Sedation in the Rural ER

ABSTRACT the first chapter,

Awake regional versus general anesthesia in preterms and ex-preterm infants for herniotomy

AUSTRALIAN COLLEGE OF VETERINARY SCIENTISTS CHAPTER OF VETERINARY PHARMACOLOGY

Pharmacokinetics of propofol when given by intravenous

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

Propofol 2% (20 mg/1 ml) MCT Fresenius emulsion for injection or infusion

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

POST TEST: PROCEDURAL SEDATION

Anaesthetic Plan And The Practical Conduct Of Anaesthesia. Dr.S.Vashisht Hillingdon Hospital

Anaesthesia and induction in neonatal companion animals

Sleep Apnea and ifficulty in Extubation. Jean Louis BOURGAIN May 15, 2016

Horses, dogs, cats, ornamental birds, reptiles, rats, mice, hamsters, chinchillas, gerbils, guinea pigs and ferrets.

RAPIFEN DATA SHEET 1. NAME OF THE MEDICINE 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 3. PHARMACEUTICAL FORM 4. CLINICAL PARTICULARS

Pharmacology of intravenous anaesthetic drug in hypovolemic shock

Adverse drug reactions. Dr. Mark Haworth MBChB DA MRCA

MR04A3 An isoindoline derivative, New Sedative/Anesthetic Agent

SEDATION FOR SMALL PROCEDURES

Anaesthesia for the geriatric dog and cat

Understanding Your Pet's Oral Treatment Plan at Interbay Veterinary Care Center

SEEING KETAMINE IN A NEW LIGHT

Proceedings of the 36th World Small Animal Veterinary Congress WSAVA

INTRAVENOUS DRUGS USED FOR THE

SUMMARY OF PRODUCT CHARACTERISTICS

DEEP SEDATION TEST QUESTIONS

ADVANCED PATIENT MONITORING DURING ANAESTHESIA: PART TWO

Transcription:

www.ivis.org Proceedings of the 36th World Small Animal Veterinary Congress WSAVA Oct. 14-17, 2011 Jeju, Korea Next Congress: Reprinted in IVIS with the permission of WSAVA http://www.ivis.org

14(Fri) ~ 17(Mon) October 2011 ICC Jeju, Korea 2011 WSAVA FASAVA World Congress www.wsava2011.org AP-C21 AFTER THIOPENTAL? OPTIONS FOR SHORT TERM INJECTABLE ANAESTHESIA KW Clarke, MA, VetMB, DVetMed, DVA, Dip ECVA MRCA, FRCVS Hon Prof. of Veterinary Anaesthesia, Royal Veterinary College Hatfield, Hertfordshire, AL9 7TA, UK Introduction Thiopental, and other barbiturates have been the mainstay for induction of anaesthesia since the 1940s. Over the past 30 years they have been replaced gradually, mainly by propofol and ketamine, and now can be difficult to obtain. This presentation will consider what is currently and easily available for induction of anaesthesia, the advantages and disadvantages for use in both dogs and cats in the practice situation, and will concentrate then on what is (relatively) new or controversial. This presentation will consider (a) Some general principles of use of injectable anaesthetic agents in small animals. (b) Brief revision of most relevant clinical pharmacology, in particular re unwanted side effects. (c) What s new or controversial? (d) In the verbal presentation, some suggested protocols for induction of, or very short-term, anaesthesia. General Principles 1. A cat is not a small dog! The cat s lack of glucuronyl transferes enzymes mean that metabolism of some drugs (in particular propofol) is delayed, and that some of the solvents or preservatives may be cumulative and/or toxic. 2. Once a drug is injected, it can only be removed by metabolism- this may vary with species or breed and may be influenced by disease states. 3. The dose of anaesthetic required will vary with the premedication used (combinations may have synergistic effects), and with the clinical state of the patient. 4. Some agents used in anaesthetic combinations (alpha 2 adrenoceptor agonists, benzodiazepines, opioids) CAN be antagonised-it is important to match duration of antagonist and agonist. 5. Route of administration - Intravenous (IV) best as easiest to judge depth, BUT not all agents work in a circulation time (thiopental does so, but pentobarbitone not), so effect is delayed. IV administration is 2011 WSAVA FASAVA World Congress Proceedings 59

usually best given slowly. Intramuscular (IM) or similar is always second best - depth of anaesthesia achieved is much less controllable and depend is on speed of uptake. 6. ALL anaesthetics are respiratory depressant, even if the animal breaths fast, so using injectable agents still needs OXYGEN, a clear AIRWAY, the ability to VENTILATE if necessary and excellent MONITORING. Anaesthetic agents/combinations A (very) brief resume of the major clinically important pharmacology [1]. Thiopental. Barbiturate, presented as solid to dissolve in water. Irritant extravascularly. IV route only. Rapid onset of anaesthesia (one circulation time) initital recovery by re-distribution, slow metabolism and cumulative. Poor analgesia. Very respiratory depressant. Vasodilates. Increases heart rate. Propofol Presentation usually in lipid, but see below. Non-irritant but sometimes pain on injection. IV route only. Rapid onset anaesthesia, non-cumulative and recovery fast-and complete, except in cats [2}. Poor analgesia. Very respiratory depressant. Cardiovascular effects as thiopental but less tachycardia. Ketamine Presentation in solution with preservatives. Many routes of administration. Non-irritant, but pain on IM injection. Onset of anaesthesia after IV injection not immediate. Excellent analgesia. Respiratory depressant but animal may breath rapidly and shallowly. Technically myocardial depression but sympathetic stimulation result in CV system being well maintained. Hallucinogenic and muscle rigidity so usually used in combination with alpha 2 agonists or benzodiazepines. Etomidate Rapidly acting IV induction agent, with rapid recovery from induction dose. Pain on injection. Venous phlebitis. Poor analgesia. Myoclonic activity. Minimal cardiovascular effects (so popular for the compromised dog). See below for concern re cortisol suppression. Alphaxalone - see detail below. Benzodiazepine/opioids may also be used to induce anaesthesia [3]. Neither of these agents work in a circulation time. What s new or currently controversial (a) Propofol in cats The major route (there are others) of metabolism of propofol is through glucuronidation of the parent drug followed by glucuro conjugation of hydroxylated metabolite via cytochrome P450 to produce other conjugates. Cats lack the enzymes necessary for this, and also are slow to metabolise the lipids in the carrier. As a result, propofol is not as short acting in the cat as in the dog. Its safe use as an induction agent, and use for short duration infusion appears satisfactory, but there is continual controversy as to whether it is suitable for longer infusions or for use several days in succession (when under experimental conditions, toxicity has occurred [2]). (b) Propofol formulations The original lecithin based formulation of propofol had to be used within a very short time of openingmaking it expensive. Since becoming out of patent, a number of new versions have included preservatives of varying efficacy. These versions state on their marketing authorisation the time after opening the vial when the product is considered safe. The most recent on the veterinary market includes benzyl alcholol 60 2011 WSAVA FASAVA World Congress Proceedings

AFTER THIOPENTAL? OPTIONS FOR SHORT TERM INJECTABLE ANAESTHESIA and, in the USA, has authorisation to be open for 28 days (some other countries give a shorter time). There are some questions as to the toxicity of the Benzyl alcohol particularly in cats, but again this is only likely to be a problem with prolonged infusions. An emulsion formulation of propofol that does not include oils and again has a long shelf life after opening has been available, but in the UK has been (possibly temporarily) withdrawn for commercial reasons. Etomidate Etomidate has not been used as a CRI in intensive care for many years since it was realised that the adrenocortical suppression in such patients increased the overall death rate, most usually from infections. In the last few years there has been considerable controversy over whether the short-term (a few hours) adrenocortical suppression it induces means that it should not be used for IV induction of anaesthesia, in particular in patients with sepsis. There is no evidence as to whether this is a potential problem in veterinary anaesthesia. Alfaxalone (3-alpha-hydroxy-5-alpha-pregnane-11,20-dione) solubalized in 2 alpha-hydroxypropyl beta cyclodextrin (HPBCD) Licenced product - Alfaxan Steroid anaesthesia is not new- over the last 50 years a number of agents have been used - the problem has been solubility. Alphaxalone /alphadalone combination solublised in cremaphor was used in humans and in cats (Saffan ) - but the cremaphor caused histamine release. Facts about Alfaxalone as Alfaxan. (a) Originally licenced in Australia, and used there now for some years. Now licenced in many countries for cats and dogs. Licensed dose rates without sedative premedication are 3mg kg-1 dogs and 5 mg kg-1 cats. Administer IV over 60 seconds. Recommended to premedicate healthy animals. (b) Effective anaesthesia on IV use in (close to) a circulation time. Induction quality usually good, but improved by sedation. Advise from practice use is to ensure anaesthesia is adequate before endotracheal intubation, otherwise if the animal is stimulated, it wakes up! (c) Non irritant IV, or if accidental extra-vascular. It could be given IM, but volume too large for use without deep sedation. (d) Short half-life, non-cumulative. Metabolised by the liver. (e) Very good safety margin, especially if ventilate (massive overdose may causes apnoea). (f) No evidence of histamine release. (g) Can be used together (not in same syringe) with most commonly used sedatives, analgesics, or subsequent inhalation agents. (h) Cardiovascular effects - minimal at clinical, or even heavy clinical doses [3,4,5]- after this (supraclinical doses for licensing procedures) dose dependant fall in blood pressure and systemic vascular resistance. (i) transient apnoea if injected fast - more prolonged at massive overdose. (j) Can get some disturbed recoveries. These are much less likely to happen if extubation is whilst anaesthesia is still deep, and the animal allowed to recover somewhere quiet. 2011 WSAVA FASAVA World Congress Proceedings 61

References 1. Hall LW, Clarke KW and Trim CM. 2001. Chapter 5 In Veterinary Anaesthesia. WB Saunders, London. Pgs 113-131. 2. Andress JL, Day TK, Day D. 1995 The effects of consecutive day propofol anesthesia on feline red blood cells. Vet Surg 24, 277-82. 3.Psatha E, Alibhai HI, Jimenez-Lozano A et al,2011. Clinical efficacy and cardiorespiratory effects of alfaxalone, or diazepam/fentanyl for induction of anaesthesia in dogs that are a poor anaesthetic risk. Vet Anaesth Analg 38, 24-36. 4.Muir W, Lerche P, Wiese A et al, 2008. Cardiorespiratory and anesthetic effects of clinical and supraclinical doses of alphaxalone in dogs. Vet Anaesth Analg 35, 1-12. 5. Muir W, Lerche P, Wiese A et al, 2009 Cardiorespiratory and anesthetic effects of clinical and supraclinical doses of alphaxalone in cats. Vet Anaesth Analg 36, 42-54 62 2011 WSAVA FASAVA World Congress Proceedings